 Connection
Catherine Derington to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Catherine Derington has written about Adrenergic beta-Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.908 |
|
|
|
-
Derington CG, Berchie RO, Mohanty AF, Jacobs JA, Xu Y, King JB, Rethy L, Cushman WC, Zickmund SL, Ho PM, Raghavan S, Cohen JB, Bress AP. First-Line ß-Blocker Use for Hypertension in the Veterans Health Administration. JAMA Netw Open. 2025 Aug 01; 8(8):e2529026.
Score: 0.812
-
Jacobs JA, Ayodele I, Bress AP, Sterling MR, Pandey A, Derington CG, Zheutlin AR, Shah KS, Greene SJ, Alhanti B, Blanco R, Fonarow GC. Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure. Circ Heart Fail. 2025 Jan; 18(1):e012357.
Score: 0.048
-
Xu Y, Derington CG, Addo DK, He T, Jacobs JA, Mohanty AF, An J, Cushman WC, Ho PM, Bellows BK, Cohen JB, Bress AP. Trends in Initial Antihypertensive Medication Prescribing Among >2.8?Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. J Am Heart Assoc. 2024 Oct 15; 13(20):e036557.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|